Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | A. Diab, C. Haymaker, M. Uemura, R. Murthy, M. James, J. Geib, M. Cornfeld, S. Swann, C. Yee, J. Wargo, R. Amaria, S. Patel, H. Tawbi, I. Glitza, S. Woodman, W-J. Hwu, M.A. Davies, W. Overwijk, C. Bernatchez, P. Hwu | ||||||||||||
Title | A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma | ||||||||||||
|
|||||||||||||
URL | http://www.esmo.org/Conferences/ESMO-2017-Congress/Programme | ||||||||||||
Abstract Text |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|